Managing Anemia in Cancer Patients With CKD
A summary of Dr. Jeffrey S. Berns’ presentation that will be given at the National Kidney Foundation’s 2016 Spring Clinical Meetings in Boston, MA.
A summary of Dr. Jeffrey S. Berns’ presentation that will be given at the National Kidney Foundation’s 2016 Spring Clinical Meetings in Boston, MA.
As the rate of acceleration in ESRD incidence decline, physicians should expect heightened battles for the ESRD fountains.
A summary of Dr. Ronald D. Perrone’s presentation that will be given at the National Kidney Foundation’s 2016 Spring Clinical Meetings in Boston, MA.
Detection of high Gleason grade tumors is not significantly improved versus standard 12-core biopsy.
The phosphodiesterase type 5 (PDE5) inhibitor, sildenafil, improved passage of distal ureteric stones 5-10 mm in diameter.
Fellowship positions go unfilled as the US faces expanding population of kidney disease patients.
Three quarters of patients experienced significant improvements in lower urinary tract symptoms and quality of life observed and were satisfied with treatment.
Patients’ median bladder capacity improved from 150 to 200 mL and continence improved in nearly 90% of patients.
Current smoking is independently associated with a greater than 2-fold increased odds of hospital readmission after radical cystectomy.
In these patients, systolic blood pressure at night was elevated by an average of 2.9 mm Hg.